The Effect of Aspirin as an Irreversible COX1 Inhibitor in Preventing Non-Valvular Atrial Fibrillation After Coronary Bypass Surgery.
CONCLUSIONS: According to the results of our study, we found that the aspirin used in preoperative period may prevent non-valvular atrial fibrillation in the postoperative period. In relation to these results, we found that hospital stay and hospital expenses decreased.
PMID: 31013226 [PubMed - in process]
Source: The Heart Surgery Forum - Category: Cardiovascular & Thoracic Surgery Authors: Erkut B, Ates A Tags: Heart Surg Forum Source Type: research
More News: Aspirin | Atrial Fibrillation | Cardiology | Cardiovascular & Thoracic Surgery | Coronary Artery Bypass Graft | Heart | Intensive Care | Study